Christopher Booth MD FRCPC is a Medical Oncologist and Health Services Researcher at Queen’s University in Kingston, Canada. He is a Professor of Oncology and Public Health Sciences and Director of the Division of Cancer Care and Epidemiology at Queen’s Cancer Research Institute. Dr. Booth’s research program explores access, quality, and value of cancer care. He serves as policy advisor to the World Health Organization and across health systems of Canada and many other countries. Dr. Booth has published more than 400 peer-reviewed manuscripts. He was Study Co-Chair of the Canadian Cancer Trials Group CO.21 CHALLENGE trial of “adjuvant exercise” in colon cancer which was published in the New England Journal of Medicine in 2025. In 2022 he received the Exceptional Healer Award at Kingston Health Sciences Centre for embodying compassion, respect, and clinical excellence. He was inducted as a Fellow of the Canadian Academy of Health Sciences in 2022. Dr. Booth is one of the founding leaders of the Common Sense Oncology initiative.

Ms. Aniek Schouten has been working as a junior researcher in the team Health Economic Evaluation at the UMC Utrecht since 2022, and has conducted a wide variety of health economic analyses across different disease areas. She is also doing a part-time PhD on the methods of conducting health economic evaluations alongside multinational trials. 

Dr. Anouk Hiensch works as an assistant professor at the Julius Center for Health Sciences and Primary Care, UMC Utrecht in The Netherlands. Her research focuses on elucidating the underlying mechanisms of the beneficial effects of exercise in patients with cancer. Anouk is the scientific coordinator of two international randomized controlled exercise trials and involved in several national exercise-oncology trials.

Dr. Rafael Deminice is an Associate Professor of Exercise Physiology at the State University of Londrina (UEL). His research focuses on the interface between cancer, muscle physiology, and exercise, particularly on cancer-related sarcopenia, oxidative stress, and metabolic adaptations. He has mentored over 20 graduate students and leads the NGO Correndo Contra o Câncer, promoting physical activity among cancer patients. Professor Deminice collaborates nationally and internationally on projects involving clinical and experimental oncology.

Dr. Alejandro Lucia, MD PhD is a Professor in Exercise Physiology at the Universidad Europea de Madrid’s Faculty of Medicine, Health and Sports, located in Madrid, Spain. His main interest is to build scientific evidence, from an integrative, holistic perspective, on the preventive–and often therapeutic–effects of physical exercise in several conditions (exercise is medicine) (e.g., pediatric cancer, glycogenosis type V, among several other conditions) as well as in special populations (pregnant women, frail/hospitalized older people). His team also works to study the different body responses and adaptations to exertion––including the so-called athlete’s heart and use mechanistic approaches when needed (preclinical disease models, omics).

Dr. Eisuke Ochi is a professor at Hosei University, Graduate School of Sports and Health Studies and Faculty of Bioscience and Applied Chemistry. He is an exercise physiologist focusing on exercise oncology.  He contributes to survivorship exercise guidance in Japan, and Cancer rehabilitation guidelines, leads education and implementation initiatives within the Japanese Association of Supportive Care in Cancer (JASCC) Exercise Oncology Working Group, and collaborates on multicenter projects spanning prehabilitation and programs for older adults. His work emphasizes pragmatic trial design, cardiorespiratory fitness and physical function as actionable clinical targets, and the translation of evidence into referral and delivery models. He is active in JASCC and the ACSM Cancer Special Interest Group.

Dr. Kerri Winters-Stone, is an exercise scientist and the Penny and Phil Knight Endowed Professor in Cancer Research Innovation at the OHSU Knight Cancer Institute, an NCI-designated comprehensive cancer center. She is an exercise scientist by training and before turning her focus to cancer survivorship, developed prescriptive exercise programs to combat osteoporosis and falls associated with aging. For the last 20 years her research has focused on the effects of cancer treatment on musculoskeletal and neuromuscular health and the use of exercise as a countermeasure to reduce falls and fractures and optimize functioning in cancer survivors. She has conducted 15 controlled clinical exercise trials that have trained over 2500 cancer survivors in different exercise modalities that are used as specific countermeasures to treatment-related toxicities. She has also co-led the update of the American College of Sports Medicine Exercise Guidelines for Cancer Survivors, released in October 2019 and is leading an NCI funded effort to develop consensus-based exercise guidelines for older cancer survivors.

Dr. David Bartlett is a Senior Lecturer of Exercise Immunology at the University of Surrey in England and Adjunct Assistant Professor at the Duke Cancer Institute in North Carolina, USA. His research focuses on understanding how physical activity and exercise influence immune function, cancer development, and survivorship. As an expert in blood‑cancer–related immunology, he investigates how behavioural and physiological stimuli can modulate host defence, treatment tolerance, and long‑term health outcomes in people living with and beyond cancer. His work integrates clinical exercise physiology, immunology, and translational cancer science, with a particular interest in mechanistic studies that uncover how exercise shapes systemic inflammation, immune ageing, and patient resilience across the cancer care pathway.